Viewing Study NCT05662904

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2026-04-13 @ 2:00 AM
Study NCT ID: NCT05662904
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-14
First Post: 2022-12-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
Sponsor: German Cancer Research Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Acute Myeloid Leukemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AML View
None allogeneic stem cell transplantation View
None gene editing View
None chemotherapy resistance View